Cargando…
Small-Molecule Inhibitors That Target Protein–Protein Interactions in the RAD51 Family of Recombinases
The development of small molecules that inhibit protein–protein interactions continues to be a challenge in chemical biology and drug discovery. Herein we report the development of indole-based fragments that bind in a shallow surface pocket of a humanised surrogate of RAD51. RAD51 is an ATP-depende...
Autores principales: | Scott, Duncan E, Coyne, Anthony G, Venkitaraman, Ashok, Blundell, Tom L, Abell, Chris, Hyvönen, Marko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506530/ https://www.ncbi.nlm.nih.gov/pubmed/25470112 http://dx.doi.org/10.1002/cmdc.201402428 |
Ejemplares similares
-
ATP half‐sites in RadA and RAD51 recombinases bind nucleotides
por: Marsh, May E., et al.
Publicado: (2016) -
Engineering Archeal Surrogate Systems for the Development of Protein–Protein Interaction Inhibitors against Human RAD51
por: Moschetti, Tommaso, et al.
Publicado: (2016) -
Structure‐activity relationship of the peptide binding‐motif mediating the BRCA2:RAD51 protein–protein interaction
por: Scott, Duncan E., et al.
Publicado: (2016) -
Using a Fragment-Based Approach To Target Protein–Protein Interactions
por: Scott, Duncan E, et al.
Publicado: (2013) -
A small-molecule inhibitor of the BRCA2-RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell death
por: Scott, Duncan E., et al.
Publicado: (2021)